It may surprise some to know there are over 200 new diabetes medications in the pipeline. It looks like big pharma realise diabetes is the new Klondike gold rush. With evidence building fast against the $30 billion a year statin con, a new mega earner is needed to keep the trough filled. Whether these new diabetes drugs work probably does not matter, if they kill people, not a problem. As long as the profits exceed the fines and compensation payouts to the victims and their families, all fair in love and war. Patients are considered collateral damage. As Stalin once said, “The death of one man is a tragedy. The death of millions is a statistic”
FDA approves three new drugs for type two diabetes.
"All three drugs contain a new active ingredient, alogliptin, either alone or in combination with other, previously approved medications. The newly approved drugs include Nesina (alogliptin), Kazano (alogliptin plus metformin) and Oseni (alogliptin plus pioglitazone), the FDA said in a news release.
The FDA urges that the new medications be used in combination with a healthy diet and exercise to help bring diabetes under control. All of the drugs underwent study either as stand-alone products or used alongside standard diabetes medications such as sulfonyureas or insulin. In the case of Nesina, the drug showed safety and effectiveness across 14 clinical trials, involving more than 8,500 patients, according to the FDA. The most common side effects included stuffy or runny nose, headache, and upper respiratory tract infections.
The agency is also requesting that a "boxed warning" be included on Kazano's labeling, highlighting the potential risk of lactic acidosis (lactic acid buildup in the blood), which can occur in products containing metformin. Oseni was studied in four clinical trials involving more than 1,500 patients, the FDA noted. Side effects were similar to those seen with Nesina, as well as back pain. Oseni's labeling will also carry a boxed warning, this time cautioning users about the risk for heart failure that accompanies drugs containing pioglitazone."
So, we have three new drugs that come with lot’s of health warnings and side effects from upper respiratory tract infections to back pain. Labelling will also carry a boxed warning, this time cautioning users about the risk for heart failure that accompanies drugs containing pioglitazone. The lowering of HbA1c will be minimal and entirely negated by a donut, well that’s progress for you.
Please note these vegetables do not cause dangerous side effects and do not carry black box warnings for cancer or heart attack.
Three new diabetes drugs link here.
Two hundred and twenty one new diabetes drugs link here.
No comments:
Post a Comment